Amita Mistry

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Fred R. Hirsch, Abigail McElhinny, Dave Stanforth et al. · Journal of Thoracic Oncology · 2016 · 1.3K citations · Full text

Medicine, Cancer Biology, Oncology +14

Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma

Marlon C. Rebelatto, Anita Midha, Amita Mistry et al. · Diagnostic Pathology · 2016 · 179 citations · Full text

Medicine, Oncology, Cancer Immunology +16

Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3N

Jacquelyn Smith, Mark D. Robida, Krista Acosta et al. · Diagnostic Pathology · 2016 · 72 citations · Full text

Medicine, Immunology, Oncology +17

Analytical Validation and Clinical Utility of an Immunohistochemical Programmed Death Ligand-1 Diagnostic Assay and Combined Tumor and Immune Cell Scoring Algorithm for Durvalumab in Urothelial Carcinoma

Magdalena Zając, Anne-Marie Boothman, Yong Ben et al. · Archives of Pathology & Laboratory Medicine · 2018 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Development of a PD-L1 companion diagnostic assay for treatment with MEDI4736 in NSCLC and SCCHN patients.

Marlon C. Rebelatto, Amita Mistry, Costi Sabalos et al. · Journal of Clinical Oncology · 2015 · 29 citations

Medicine, Immunology, Oncology +17